Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. submitted his first DEA application to manufacture marijuana for use in medical research.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

The Joint Blog

JUNE 2, 2020

In 2007, he acknowledged that ending raids on medical marijuana users was necessary, but that he believed that “there’s got to be a better answer than marijuana” for addressing health issues and symptoms. The issue of legalization is left to the state, taking the health and safety of the public into account. During her speech on Feb.

Decriminalization 29

Decriminalization Recreational Advocacy Policy 29

Meadow

JULY 13, 2018

Back in 2007, it said we don’t want anymore cannabis businesses and despite a general prohibition, we still had more cannabis businesses than any other location. If you heard a couple weeks ago, maybe a month ago, DEA, FBI, IRS all came in Sacramento and they busted a whole bunch of homes. It’s every square inch of it.

Wellness and Beauty 40

Wellness and Beauty Consumption Policy Cannabis 40

Cannabis Law Report

MARCH 25, 2019

The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. But DEA regulators determined after both of those reviews that marijuana should remain a Schedule I substance. 2003, 2004, 2007, 2008, Nov. 2003, 2004, 2007, 2008, Nov. 6059, 6074, 6075, 6077(a), (b), 6253, Nov.

Banking 45

Banking Law Marijuana State Laws 45